Skip to content

Drug interactions

Cenobamate + Crizotinib

Severity: Moderate

Cenobamate and Crizotinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cenobamate is a CYP3A4 inducer and may reduce crizotinib exposure, risking reduced anticancer effect.

What this interaction means in plain words

Cenobamate and Crizotinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Cenobamate belongs to Central Nervous System; Crizotinib belongs to Oncology.

Evidence level: Low

Why it happens

Cenobamate induces CYP3A4, increasing crizotinib clearance.

What to do

Monitor for reduced tumor response and consider an alternative antiseizure drug without induction if feasible.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cenobamate and Crizotinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Cenobamate with Crizotinib?

MediHelp rates the interaction as moderate. Cenobamate and Crizotinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Cenobamate is a CYP3A4 inducer and may reduce crizotinib exposure, risking reduced anticancer effect.

How serious is the interaction between Cenobamate and Crizotinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for reduced tumor response and consider an alternative antiseizure drug without induction if feasible.

What other medicines interact with Crizotinib?

MediHelp also lists interactions of Crizotinib with, for example, Flibanserin, Lomitapide, Lonafarnib. The full list is on the Crizotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in